Please note that this programme may be subject to change

Click on the buttons below to view the programme for each day

Registration

Registration and refreshments

0900-1000 hours

Welcome

Welcome message from the APS Chair and opening of the PharmSci 2025 Conference
Professor Ryan Donnelly, APS Chair and Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast

1000-1010 hours

Science Chair
Lecture

“Pharmaceutical Sciences Driving the Next Generation Medicines”
Marianne Ashford, Senior Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca

1010-1050 hours

Plenary Lecture

“Promoting Cancer Nanomedicine Clinical Translation”
Professor Twan Lammers, PhD, DSc, Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Center for Biohybrid Medical Systems, RWTH Aachen University Clinic, Germany

1050-1135 hours

Exhibitors Showcase

Quick fire presentations from our PharmSci 2025 Exhibitors

1135-1205 hours

Parallel Science Session 1
1400-1530 hours

Skin Forum
“Overcoming the skin barrier: physical and computational approaches”

Session Chair: Professor James Birchall, Professor of Pharmaceutical Sciences and Deputy Head of School, School of Pharmacy and Pharmaceutical Sciences,
Cardiff University, Wales, UK

Advanced Therapy & Medicinal Products Focus Group

Session Chair: Purav Shah, (M.Sc. (Hons), B. Pharm), Chief Scientific Officer, Thoroughbred Remedies Manufacturing. TRM, Ireland

“Microneedles for Vaccines and topical drug delivery“
Dr Faz Chowdhury, CEO, Landmark Vaccines Limited, Loughborough, UK

“Molecular Simulations of Skin-Lipid Membranes and Drug Permeability Enhancement”
Dr Rebecca Notman, Associate Professor in Computational Biochemistry, School of Biochemistry, University of Bristol, UK

Podium presentations from abstract submissions

“Optimising the Interface between Medical Devices and Soft Tissue for the Delivery of Biologics and Cell-based Therapies”
Dr Eoin O’Cearbhaill, Associate Professor of Biomedical Engineering, Director of the UCD Centre for Biomedical Engineering, School of Mechanical & Materials Engineering,
UCD, Ireland

“Microparticles to improve cell engraftment and transplant niche control”
Dr Lisa White, Associate Professor in Biomaterials and Regenerative Medicine, University of Nottingham

“Rationalising mAb developability testing”
Dr Leon F Willis MRSC, Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, University of Leeds, UK

Podium presentations from abstract submissions

“Air-Liquid Interface Organ-on-Chip Models: Advancing Drug Development
for Barrier Tissues”
Dr Prajakta Dandekar Jain, UGC Assistant Professor in Engineering Sciences, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (ICT), Mumbai, India

“In vitro tools for testing of non-oral complex formulations”
Samir Haddouchi, Managing Director, SOTAX Pharma Services, France

“Predicting human subcutaneous bioavailability of monoclonal antibodies using an integrated
in-vitro/in-silico approach”
Dr Belal Hanafy, Senior Scientist, Pharmaceutical Sciences, Advanced Drug Delivery, AstraZeneca UK

Podium presentations from abstract submissions

Parallel Science Session 2
1600-1730 hours

Biopharmaceutics Focus Group – “Biopharmaceutics challenges with complex delivery of oral molecule”

Session Chair: Chris Roe, Senior Research Fellow, Scientific Consulting, Quotient Sciences, UK

Drugs from Natural Sources Focus Group
“The Next Generation of (Herbal) Medicines – Sustainability meets Drug Development”

Emerging Technologies Focus Group
“Translational applications of 3D printing of medicines in clinical settings”

Session Chair: Dr Atheer Awad, Lecturer in Pharmaceutics, University of Hertfordshire, UK

“Formulation approaches for oral peptide administration: which strategies
are most promising”
David Brayden, Ph.D., FAAPS, MRIA, Professor of Advanced Drug Delivery, Veterinary Sciences Centre, University College Dublin, Ireland

“Presentation Title”
Speaker t.b.c.

“Modelling the effect of a permeability enhancer on the absorption of
a poorly permeable large
molecule: A retrospective analysis”
Dr Ricardo Diaz de Leon Ortega, Modelling and Simulation Research Fellow, Quotient Sciences, UK

Podium presentations from abstract submissions

“Future-Proof Medicine: The Evolving Role Of Sustainability In Research & Development”
Dr Gaia A. Scalabrino, NatPro Executive Director, NatPro Trinity Centre for Natural Products Research, Trinity College Dublin, Ireland

“Conservation and sustainable use of medicinal plants: How do they pay into our SDG compliance? “
Dr Olaf Kelber, Scientific Strategy Phytomedicines, Bayer Distinguished Science Fellow, Research and Development, Phytomedicines Supply and Development Center, Bayer Consumer Health, Germany

Podium presentations from abstract submissions

“Implementation of 3D-printing into a hospital’s closed-loop medication management system”
Dr Adrin Dadkhah, Hospital Pharmacy and Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf, Germany

“Clinical implementation of 3D printing in hospitals and pharmacies”
Dr Alvaro Goyanes, CEO and Co-founder, FABRX Limited, UK

“Commercial medication in 3D printed medicines – Source what you have”
Julian Quodbach, PhD, Assistant Professor, Division of Pharmaceutics, Utrecht Institute of Pharmaceutical Sciences

Podium presentations from abstract submissions

Poster Session

Opportunity to view posters and network with presenters

Registration

Registration and refreshments

0830-0900 hours

Welcome

Welcome from the APS Chair
Professor Ryan Donnelly, APS Chair and Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast

0900-0905 hours

Plenary Lecture

“The RNA Revolution: From Vaccines to Therapeutic Genome Editing in a Targeted Manner”
Professor Dan Peer, Director, Laboratory of Precision NanoMedicines, Tel Aviv University, Israel

0905-0950 hours

Award

Presentation of Innovative Science Award
Sponsored and presented by GSK

0950-0955 hours

Award Lecture

Presentation by Innovative Science Award Winner

0955-1030 hours

Parallel Science Session 1
1100-1230 hours

Process Engineering Focus Group

New Scientist Focus Group

Joint Pharmaceutical Analysis Group (JPAG)

Session Chair: Professor Laura Waters, University of Huddersfield, UK

“Don’t believe the hype : D&D implementation at Novartis”
Dr Sarah David, Scientific Advisor, Pharmaceutical Development,
Novartis, Basel

“Application of Process Modelling and Digital Tools in Pharmaceutical Development and Manufacturing”
Dr Ranjit Dhenge, MSAT Process Engineering & Analytics Team Leader, GSK, UK

Podium presentations from abstract submissions

“From Lab to Life: crafting an academic career in Pharmaceutical Sciences”
Dr Sara Cordeiro, Senior Lecturer in Pharmaceutics, MPharm Director, Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, UK

“Bath, BMS and Beyond: A Career in Pharmaceutical Science“
Mike Tobyn, PhD, Senior Scientific Director, Materials Science and Engineering, Bristol Myers Squibb, UK

Podium presentations from abstract submissions

“Advanced Analytics: Developability assessment of new modality therapeutics”
Dr Zahra Rattray, Reader in Translational Pharmaceutics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, UK

“Biosensors for Forensic Analysis”
Maxine den Hartog, PhD Candidate, King’s Forensic Biochemistry Group, King’s College London, UK

Podium presentations from abstract submissions

Parallel Science Session 2
1400-1530 hours

Nanomedicines Focus Group
“Nanomedicine to enhance
next-generation therapies”

Session Chair: Professor Elaine Ferguson, Professor in Polymer Therapeutics, School of Dentistry, Cardiff University, UK and Professor Neill Liptrott, Chair in Pharmacology and Immunocompatibility, Department of Pharmacology and Therapeutics, University of Liverpool, UK

Regulatory Focus Group

“Highlights from Posters”

“Deep Diving into Endocytic Pathways to Unravel the Delivery Efficiency of Nanomedicines”
Arwyn T. Jones, Professor of Membrane Traffic and Drug Delivery, School of Pharmacy & Pharmaceutical Sciences, Cardiff University, Wales, UK

Podium presentations from abstract submissions

“How AI will influence the future of medicine development and manufacture”
Professor Alastair Florence, Director, CMAC, University of Strathclyde, UK

“Industry Case Study – Improving product quality with AI during visual inspection”
Speaker t.b.c.

“Industry Case Study – Machine Learning in Stability Analysis & how AI will influence in the future”
Speaker t.b.c.

“Regulating for the AI future”
Speaker t.b.c., MHRA

Award

Presentation of APS Academy Medal Award
Sponsored by:

1630-1635 hours

Plenary Lecture

Presentation by APS Academy Medal Award Winner
“Designing and translating new biomaterials for therapeutics and disease detection”
Professor Dame Molly Stevens DBE FRS FREng, John Black Professor of Bionanoscience, University of Oxford and a part-time Professor, Imperial College London and the Karolinska Institute, UK

1635-1720 hours

Registration

Registration and refreshments

0830-0900 hours

Welcome

Welcome from the APS Chair
Professor Ryan Donnelly, APS Chair and Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast

0900-0905 hours

Award

Presentation of APS Award

Sponsored by:

0905-0910 hours

Award Lecture

Presentation by APS Award Winner

0910-0935 hours

Award

Presentation of APS Emerging Scientist Award
Sponsored by:

0935-0940 hours

Award Lecture

Presentation by APS Emerging Scientist Award Winner

0940-1015 hours

Parallel Science Session 1
1130-1300 hours

Biopharmaceutics Focus Group
“Biopharmaceutics challenges with complex delivery of new modalities”

Session Chair: Chris Roe, Senior Research Fellow, Scientific Consulting, Quotient Sciences, UK

Material Science Focus Group

Inhaled

Session Chair: Chris Vernall, EVP, Business Development, HCmed Innovations, UK

“Considerations and opportunities for the oral delivery of peptides and oligonucleotides“
Dr Nigel Davies, (BPharm, MRPHarmS, PhD), Senior Principal Scientist in Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Sweden

“Current landscape on the complexities associated with the delivery of long-acting drug formulations and long-acting injectables which may impact biopharmaceutics“
Professor Neill Liptrott, Chair in Pharmacology and Immunocompatibility, Department of Pharmacology and Therapeutics, University of Liverpool, UK

“Can we predict the bioavailability of monoclonal antibodies after subcutaneous dosing? A physiologically based pharmacokinetic modelling study.“
Dr Felix Stader PhD, Certara Predictive Technologies, UK

Podium presentations from abstract submissions

“Development of long-acting therapeutics: Challenges and opportunities“
Dr James Hobson, Research Coordinator, Centre for Excellence in Long-acting Therapeutics, University of Liverpool, UK

“Macromolecules: From Advanced Drug Delivery Systems to Precision Designed Actives“
Kevin Treacher, Principal Scientist, Global Product Development, Pharmaceutical Technology & Development, AstraZeneca, UK

Podium presentations from abstract submissions

“Inhaled RNA therapy – bridging the current gaps“
Dr Jenny Lam, Associate Professor of Pharmaceutics,
UCL School of Pharmacy, UK

“Presentation Title“
Speaker t.b.c.

Podium presentations from abstract submissions

Award

Presentation of Poster Awards

1300-1330 hours

Close

Concluding remarks from APS Chair and close of Conference
Professor Ryan Donnelly, APS Chair and Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast

1330-1340 hours

If you have any questions please send us an email to info@apsgb.co.uk and one of our team will come back to you.